Peng Enuo, Ai Miao, Tan Xiaojun, Zhao Xingping, Xu Dabao
Reproductive Center, Third Xiangya Hospital, Central South University, Changsha 410013.
Reproductive Center, Xiangtan Central Hospital, Xiangtan 411100.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Jan 28;50(1):45-51. doi: 10.11817/j.issn.1672-7347.2025.240408.
Platelet-rich plasma (PRP) treatment has been reported to improve ovarian function in women, but the relationship between the dose and frequency of PRP treatment and its therapeutic effect remains unclear. This study aims to evaluate the efficacy of single and double PRP treatments for diminished ovarian reserve (DOR).
A total of 65 patients treated at the Reproductive Center of Xiangtan Central Hospital from September 2020 to October 2022 were randomly divided into 4 groups: A single PRP treatment group (21 patients, PRP treatment once), a double PRP treatment group (15 patients, PRP treatment twice), a blank control group (15 patients), and an artificial cycle control group (14 patients, treated with estrogen and progesterone). The differences in baseline follicle-stimulating hormone (FSH), antral follicle count (AFC), ovarian volume, number of oocytes retrieved, number of good quality embryos, and pregnancy outcomes before and after treatment were compared among the 4 groups.
Compared to before treatment, both single and double PRP treatment groups showed a significant reduction in FSH, and an increase in AFC, ovarian volume, numbers of oocytes retrieved, and number of MII oocytes (all <0.05). Compared to the blank control group, the single and double PRP groups showed a decrease in FSH, with an increase in AFC, number of oocytes retrieved, and number of MII oocytes (all <0.05). The rates of good quality embryos, clinical pregnancy rate, and live birth rate in the single and double PRP groups were higher than those in the blank control group and artificial cycle control groups, but the differences were not statistically significant (all >0.05). Compared to the single PRP treatment group, the double PRP group had lower FSH and higher AFC, but the differences were not statistically significant (both >0.05).
Both single and double PRP ovarian injections can effectively improve ovarian reserve function in DOR patients and enhance ovarian response. Compared to single PRP ovarian injection, double PRP ovarian injection shows a trend of better improvement in ovarian reserve function.
有报道称富血小板血浆(PRP)治疗可改善女性卵巢功能,但PRP治疗的剂量和频率与其治疗效果之间的关系仍不明确。本研究旨在评估单次和双次PRP治疗对卵巢储备功能减退(DOR)的疗效。
选取2020年9月至2022年10月在湘潭市中心医院生殖中心接受治疗的65例患者,随机分为4组:单次PRP治疗组(21例患者,PRP治疗1次)、双次PRP治疗组(15例患者,PRP治疗2次)、空白对照组(15例患者)和人工周期对照组(14例患者,接受雌激素和孕激素治疗)。比较4组治疗前后基础卵泡刺激素(FSH)、窦卵泡计数(AFC)、卵巢体积、取卵数、优质胚胎数及妊娠结局的差异。
与治疗前相比,单次和双次PRP治疗组的FSH均显著降低,AFC、卵巢体积、取卵数及MII期卵母细胞数均增加(均P<0.05)。与空白对照组相比,单次和双次PRP组的FSH降低,AFC、取卵数及MII期卵母细胞数增加(均P<0.05)。单次和双次PRP组的优质胚胎率、临床妊娠率和活产率均高于空白对照组和人工周期对照组,但差异无统计学意义(均P>0.05)。与单次PRP治疗组相比,双次PRP组的FSH较低,AFC较高,但差异无统计学意义(均P>0.05)。
单次和双次PRP卵巢注射均可有效改善DOR患者的卵巢储备功能,增强卵巢反应。与单次PRP卵巢注射相比,双次PRP卵巢注射在改善卵巢储备功能方面有更好的趋势。